HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Nishikibe Selected Research

J-105859

12/2000Marked reduction of mortality in salt-loaded Dahl salt-sensitive rats by the new, selective endothelin ETA receptor antagonist, J-105859.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Nishikibe Research Topics

Disease

3Hypertension (High Blood Pressure)
07/2002 - 11/2000
3Heart Failure
07/2002 - 01/2001
2Thrombosis (Thrombus)
04/2000 - 03/2000
1Pulmonary Hypertension
07/2002
1Bradycardia
05/2001
1Tremor (Tremors)
05/2001
1Tachycardia (Tachyarrhythmias)
01/2001
1Stroke (Strokes)
11/2000
1Pathologic Constriction (Stenosis)
04/2000
1Pulmonary Embolism
03/2000

Drug/Important Bio-Agent (IBA)

2Endothelin-1 (Endothelin 1)IBA
07/2002 - 08/2001
2Endothelins (Endothelin)IBA
08/2001 - 11/2000
2Losartan (Cozaar)FDA LinkGeneric
01/2001 - 11/2000
2SaltsIBA
12/2000 - 11/2000
1Peptides (Polypeptides)IBA
07/2002
1antineoplaston A10 (A 10)IBA
05/2001
1Acetylcholine (Acetylcholine Chloride)FDA Link
05/2001
1OxotremorineIBA
05/2001
1losartan carboxylic acidIBA
01/2001
1J-105859IBA
12/2000
1Antihypertensive Agents (Antihypertensives)IBA
11/2000
1J 104132IBA
11/2000
1Phosphodiesterase 3 InhibitorsIBA
04/2000
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2000
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
03/2000
1IsoenzymesIBA
03/2000
1Dipyridamole (Persantine)FDA LinkGeneric
03/2000
1Cilostazol (Pletal)FDA LinkGeneric
03/2000

Therapy/Procedure

1Oral Administration
11/2000